NCT06080061Recruiting
Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer
Phase I Trial of Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer
Source: ClinicalTrials.gov · Last updated 7 Oct 2026
Brief summary (registry, in English)
The purpose of this study is to examine the use of hypofractionated accelerated radiation therapy (HART) to treat locally advanced lung cancer. Depending on the location and size of the tumor.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 45 (estimated)
- First submitted
- 6 Oct 2023
- Start date
- 25 Oct 2023
- Primary completion date
- Nov 2026
- Lead sponsor
- Stanford University
- Diseases
- Lung cancer
- NCT number
- NCT06080061
What you commit to
- Study type: Interventional
- Planned participants: 45
- From 25 Oct 2023 to the primary completion date, Nov 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Contraindication to receiving radiotherapy or systemic therapy as determined by treating radiation and medical oncologist
- Previous radiation therapy to the thorax that would result in overlapping high dose radiation fields
Age
- Age \< 18 years old
Other
- Diagnosis of interstitial pulmonary fibrosis
Who the study is looking for
- Histologically or cytologically documented malignancy of the thorax including but not limited to non-small cell lung cancer or small cell lung cancer planned for definitive therapy with fractionated radiation (60-66 Gy) and concurrent systemic therapy
- ECOG performance status of 0-2
- PET/CT or CT Imaging of Thorax
- Age ≥ 18 years old
- Ability to understand and the willingness to personally sign the written IRB approved informed consent document
- Estimated life expectancy of 12 weeks or longer
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Stanford University Coordinator of this site? Confirm its status | Palo Alto | United States | Recruiting |
| Stanford Cancer Center South Bay Coordinator of this site? Confirm its status | San Jose | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.